CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 100,000 shares at $7.09 ($709,240)
- 4 Option exercise Chief Financial Officer acquired 40,000 shares (option exercise)
- 4 Planned sale CHIEF PEOPLE OFFICER sold 125,000 shares at $6.03 ($753,188)
- 4 Planned sale CHIEF REGULATORY OFFICER sold 63,000 shares at $6.02 ($379,191)
- 4 Planned sale Chief Financial Officer sold 47,668 shares at $6.01 ($286,370)
- 4 Open-market buy Director bought 25,000 shares at $4.73 ($118,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Planned sale CHIEF REGULATORY OFFICER sold 36,750 shares at $5.01 ($184,279)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 50,000 shares at $5.02 ($251,000)
- 4 Planned sale CHIEF REGULATORY OFFICER sold 200,000 shares at $4.52 ($903,560)
- 4 Derivatives Options or other derivatives
- 4 Grant or award SEE REMARKS acquired 50,761 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 10 · 184 filings